By Jeff Overley ( February 20, 2013, 2:55 PM EST) -- Ranbaxy Laboratories Ltd. in New Jersey federal court Tuesday attacked a proposed class action targeting its generic version of Lipitor, questioning the honesty of patients allegedly harmed by pills potentially tainted with glass and saying a court-ordered larger recall would usurp regulators' authority....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.